Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-07-2021 | Bronchial Asthma | Correspondence

Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab

Authors: Hiroaki Kitamura, Yasushi Kubota, Rika Tomimasu, Haruki Hirakawa, Hiroshi Inoue, Hitomi Umeguchi, Moeko Yoshida, Hideki Akahoshi, Shiho Tsuruda, Rie Ide, Shinya Kimura, Masaharu Miyahara

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2021

Excerpt

Dear Editor, …

Astermark J (2015) FVIII inhibitors: pathogenesis and avoidance. Blood 125(13):2045–2051. https://doi.org/10.1182/blood-2014-08-535328CrossRefPubMedPubMedCentral

Franchini M, Vaglio S, Marano G, Mengoli C, Gentili S, Pupella S et al (2017) Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology 22(9):514–520. https://doi.org/10.1080/10245332.2017.1319115CrossRefPubMed

Sborov DW, Rodgers GM (2012) Acquired hemophilia A: a current review of autoantibody disease. Clin Adv Hematol Oncol 10(1):19–27PubMed

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245. https://doi.org/10.1038/clpt.1981.154CrossRef

Chaves DG, Velloso-Rodrigues C, Oliveira CA, Teixeira-Carvalho A, Santoro MM, Martins-Filho OA (2010) A shift towards a T cell cytokine deficiency along with an anti-inflammatory/regulatory microenvironment may enable the synthesis of anti-FVIII inhibitors in haemophilia A patients. Clin Exp Immunol 162(3):425–437. https://doi.org/10.1111/j.1365-2249.2010.04258.xCrossRefPubMedPubMedCentral

Pham TH, Damera G, Newbold P, Ranade K (2016) Reductions in eosinophil biomarkers by benralizumab in patients with asthma. Respir Med 111:21–29. https://doi.org/10.1016/j.rmed.2016.01.003CrossRefPubMed

Fidanci ID, Zulfikar B, Kavakli K, Ar MC, Kilinc Y, Baslar Z et al (2014) A polymorphism in the IL-5 gene is associated with inhibitor development in severe hemophilia A patients. Turk J Haematol 31(1):17–24. https://doi.org/10.4274/Tjh.2012.0197CrossRefPubMedPubMedCentral

Title: Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab
Authors: Hiroaki Kitamura
Yasushi Kubota
Rika Tomimasu
Haruki Hirakawa
Hiroshi Inoue
Hitomi Umeguchi
Moeko Yoshida
Hideki Akahoshi
Shiho Tsuruda
Rie Ide
Shinya Kimura
Masaharu Miyahara
Publication date: 01-07-2021
Publisher: Springer India
Keywords: Bronchial Asthma
Hemophilia
Hematuria
Published in: Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-020-01371-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2021

Chromosome 7q31 Amplification in Fluorescence In-Situ Hybridization: A Hallmark of Hepatosplenic Gamma Delta T Cell Lymphoma

Design and Development of Reverse Slot Blot for the Simultaneous Detection of Rare and Regional Specific Mutations in the Beta Globin Gene in Khuzestan Province of Iran

CE-HPLC Derived P2 and P3-Peaks in Health and in Hb D-Punjab and HbE States

Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience

Unmanipulated Stem Cell Boost for Mixed Chimerism in Transfusion Dependent Thalassemia

Real-world Experience of Rituximab in Immune Thrombocytopenia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer